ArticleJAMA network open2025
Breast Cancer Stage Among Ukrainian Refugees in Poland.
Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Chemotherapy Under Fire: Narratives of Patients With Cancer During Wartime.Psycho-oncology · 2025Trial
- Impact of Russian invasion on radiation therapy capacity in Ukraine: a national survey study.BMJ global health · 2026Article
- Copy number variants in BRCA1 and BRCA2 genes in Polish patients with breast and ovarian cancer.Journal of cancer research and clinical oncology · 2026Article
- A European collaborative initiative to systematically map cancer risk by migration background: the Cancer RADAR project.International journal for equity in health · 2026Article
- Challenges and strategies for delivering effective breast cancer care in conflict zones.Communications medicine · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Millions of Ukrainians displaced by war have sought refuge in Poland, posing challenges for cancer care. Determining whether these refugees present with more-advanced breast cancer is crucial for guiding resource allocation. Objective: To evaluate the associations between Ukrainian refugee status and clinical presentation of breast cancer compared with Ukrainian permanent residents in Poland and the general Polish population. Design, Setting, and Participants: This retrospective cohort study was conducted between February 2021 and February 2024 at a single tertiary oncology center (Lower Silesian Oncology, Pulmonology, and Hematology Centre, Wrocław, Poland) and included adult women with a diagnosis of stage 0 to IV breast cancer, regardless of treatment intent. Participants were categorized as Ukrainian permanent residents (UPRs), Ukrainian war refugees (UWRs), or general Polish population (GPP). Exposures: War refugee status (UWR) vs permanent residence (UPR) vs general Polish population (GPP) and a diagnosis of breast cancer. Main Outcomes and Measures: Primary outcomes were clinical stage (0-IV) at diagnosis, tumor grade (G1-G3), and age at presentation. Stage distributions and odds ratios (ORs) were evaluated using weighted logistic regression, adjusting for age and time period (before the war, first war year, and second war year). Results: Of 3259 patients, 44 were in the UWR group (mean [SD] age, 52.9 [13.5] years), 72 were in the UPR group (mean [SD] age, 49.9 [11.4] years), and 3143 were in the GPP group (mean [SD] age, 59.5 [12.6] years). Stage III to IV disease occurred in 19 patients (43.2%) in the UWR group vs 849 patients (27.0%) in the GPP group. Adjusted analysis showed that refugees had a 2.00-fold increased odds (95% CI, 1.06-3.76; P = .03) of stage III to IV disease and 2.42-fold increased odds (95% CI, 1.29-4.55; P = .006) of grade 3 tumors. Conclusions and Relevance: In this retrospective cohort study, war refugee status was associated with a higher prevalence of aggressive tumor grades and more-advanced stage disease at diagnosis. Although aggressive breast cancer subtypes are more common in younger women, the disproportionate burden of advanced disease in this cohort highlights the impact of health care access barriers and delayed presentation. These findings underscore the need for tailored strategies, such as accessible screening and early diagnostic interventions, to improve outcomes among Ukrainian refugees in Poland.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.